RARbeta1': primed to fight retinoid resistance in lung carcinogenesis.
Sabichi
Anita L
AL
Xu
Xiaochun
X
Lippman
Scott M
SM
D017398:Alternative Splicing; D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology; D001374:Azacitidine / Q000494:pharmacology; D045744:Cell Line, Tumor; D019008:Drug Resistance, Neoplasm / Q000187:drug effects; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D020033:Protein Isoforms; D018168:Receptors, Retinoic Acid / Q000378:metabolism*; D020545:Respiratory Mucosa / Q000378:metabolism / Q000473:pathology*; D047488:Retinoid X Receptors / Q000378:metabolism; D014212:Tretinoin / Q000494:pharmacology
D000964:Antimetabolites, Antineoplastic; D020033:Protein Isoforms; D018168:Receptors, Retinoic Acid; D047488:Retinoid X Receptors; C082925:retinoic acid receptor beta; D014212:Tretinoin; D001374:Azacitidine